Xenon Pharmaceuticals
XENE
#3883
Rank
โ‚น200.33 B
Marketcap
โ‚น2,617
Share price
-2.38%
Change (1 day)
-23.99%
Change (1 year)

Revenue for Xenon Pharmaceuticals (XENE)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xenon Pharmaceuticals from 2014 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A-100%
2022 โ‚น0.78 B-43.11%
2021 โ‚น1.37 B-41.67%
2020 โ‚น2.35 B383.06%
2019 โ‚น0.48 B
2018 N/A-100%
2017 โ‚น19.85 M-83.79%
2016 โ‚น0.12 B-88.16%
2015 โ‚น1.03 B-42.43%
2014 โ‚น1.79 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น22.75 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.98 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA